# Ember Therapeutics, Inc. — Form D

Ember Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-21. The offering totals $34.2M, of which $3.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-12-21
- Form: D
- Accession: 0001537900-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $34.2M
- Amount sold: $3.2M
- Remaining: $31.0M
- Investors: 1
- Date of first sale: 2011-12-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-170448

## Issuer

- Name: Ember Therapeutics, Inc.
- CIK: 0001537900
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 29 NEWBURY ST, BOSTON, MA, 02116
- Phone: 617-585-2079

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Dan Lynch | Director | Boston, MA |
| Bruce Spiegelman | Director | Boston, MA |
| Louis Tartaglia | Director | BOSTON, MA |
| Mitchell Bloom | Executive Officer | Boston, MA |
| Kevin Gillis | Executive Officer | Boston, MA |
| Louis Tartaglia | Executive Officer | BOSTON, MA |

## More

- [CIK 1537900 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1537900&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001537900-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.